Caroline Anger
IQVIA (United Kingdom) · 27 works · 3,759 citations · h-index 3
Top works
- COMPARISON OF FOUR CHEMOTHERAPY REGIMENS FOR ADVANCED NON-SMALL-CELL LUNG CANCER
- Biomarker Testing and Mutation Prevalence in Metastatic Colorectal Cancer Patients in Five European Countries Using a Large Oncology Database
- Impact of Biomarkers and Primary Tumor Location on the Metastatic Colorectal Cancer First-Line Treatment Landscape in Five European Countries
- Evolution of RAS testing in colorectal cancer in France, Germany, Italy, Spain and UK (EU5).
- Dose variation in metastatic breast cancer: Are European Medicines Agency summary of product characteristics (SmPC) being followed?
- 17P deletion and TP53 gene mutation (17P/TP53) testing behaviour and treatment patterns for chronic lymphocytic leukemia (CLL) patients in France, Germany, Italy, Spain and UK (EU5)
- Patterns of Patients Stopping Their Anti-Cancer Drug Due to Its Associated Side Effects in France, Germany, Italy, Spain and Uk (Eu5)
- 372P Microsatellite instability testing practices in colorectal cancer patients, in Europe and Asia
- MSI/MMR test usage and checkpoint inhibitor practices in Europe.
- 774P Adoption of immune checkpoint inhibitors (ICIs) in bladder cancer: Findings from a real-world study in EU5
- PCN251 - DESCRIPTIVE ANALYSIS OF THE USE OF TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKAEMIA IN EUROPE, A REAL-WORLD PERSPECTIVE
- PCV107 CLOPIDOGREL PATTERNS OF USE IN ACUTE CORONARY SYNDROME PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN FIVE EUROPEAN COUNTRIES
- P05.03.A NEXT GENERATION SEQUENCING IN HIGH-GRADE GLIOMAS IN EUROPE AND ASIA: A REAL WORLD ANALYSIS
- Treatment paradigm shift in NSCLC: Patient data analysis from 2005 to 2016
- Evolution of Molecular Diagnostic Test Usage in Solid Tumours in Western Europe: Ambition Study (Analysis of Molecular Biomarker Tests in Oncology)
- Drug treatment in melanoma: A real-world analysis across Europe and Japan
- Treatment algorithm for multiple myeloma: Real-world insights across five European countries
- Usage pattern of anticoagulants in oncology patients receiving active anticancer therapies in Europe and Asia.
- P17.09.A SYSTEMIC TREATMENT PATTERNS IN RECURRENT HIGH-GRADE GLIOMAS IN EUROPE AND ASIA: A REAL WORLD ANALYSIS
- Adoption of immuno-oncology in NSCLC, a real-world study in EU5.